Healthcare News: Patients with sickle-cell disease at higher risk for COVID-19 complications, says study

Why This Topic Matters

The topic is relevant because it connects current infectious-disease outcomes research with diagnosis coding updates for sickle-cell disorders. Readers working in coding, compliance, or hematology-related documentation may want to understand the clinical context and the scope of the ICD-10-CM changes mentioned in the article.

Article Sections

1. Study findings on sickle-cell disease, sickle-cell trait, and COVID-19

   Summarizes the reported research population, comparison groups, and the general relationship between sickle-cell conditions and COVID-19 outcomes. The section places the findings in the context of a hematology conference presentation.

2. ICD-10-CM update for sickle-cell disorder coding

   Introduces the ICD-10-CM update discussed in the article and frames the coding changes within category D57.-. This section identifies the broad scope of the newly noted diagnosis coding information.

3. Examples of new sickle-cell disorder codes

   Lists specific diagnosis codes referenced as part of the update. The section serves as a coding-oriented reference to the identifiers mentioned in the article.